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K e y  M e s s a g e s 
1. Pseudomonas aeruginosa infection is 
associated with increased production of matrix 
metalloproteinase-9 (MMP-9) from the airway 
epithelium; inappropriate expression and 
activation of MMP-9 may be associated with 
tissue injury and airway remodelling.
2. P aeruginosa exposure induces the 
phosphorylation of ERK, JNK, and p38 MAPKs 
in human airway epithelial cell line (BEAS-2B). 
Inhibition of ERK or JNK activity blocks IL-8 
and MMP-9 mRNA and protein expression in 
BEAS-2B cells infected with P aeruginosa.
3. Induction of IL-8 and MMP-9 in human bronchial 
epithelial cells by P aeruginosa infection is 
mediated via the NF-κB-mediated pathway, 
possibly through upstream ERK and JNK MAPK 
pathways.
4. P aeruginosa infection initiates an intense 
Cellular signalling pathways of matrix 
metalloproteinase gene expression by 
Pseudomonas aeruginosa–infected human 
bronchial epithelial cells
Introduction
Pseudomonas aeruginosa is a Gram-negative 
bacillus and an opportunistic pathogen that causes 
pneumonia in immunocompromised humans and 
severe pulmonary damage in non-cystic fibrosis 
bronchiectasis.1 Because of the severity of P 
aeruginosa infection, it is important to understand 
the mechanisms of the resulting epithelial injury 
and repair processes during conditions of airway 
inflammation. P aeruginosa is a pathogen in chronic 
obstructive pulmonary disease associated with an 
intense airway inflammation and poor prognosis.2,3 
The initial step of bacterial infection, crucial for 
the development of permanent colonisation at 
later stages, is the adherence of the bacteria to 
epithelial cells. The infection is associated with an 
excessive inflammatory response, characterised 
by the accumulation of large amounts of the 
polymorphonuclear leukocyte chemokine IL-8 and 
its toxic products in the airways.4 
 The matrix metalloproteinases (MMPs) are 
a family of proteolytic enzymes that degrade the 
main protein components of extracellular matrices 
and may lead to continued airway obstruction when 
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uncontrolled.5 They are produced by structural 
cells such as fibroblasts and epithelial cells, and by 
many inflammatory cells including macrophages, 
eosinophils, neutrophils, and mast cells. They are 
secreted as latent proenzymes and are converted to 
the active form by proteolytic cleavage of an amino-
terminal domain. The MMPs are important in tissue 
remodelling in the airways through their ability to 
affect the integrity of the basal lamina and the degree 
of infiltration by inflammatory cells. The balance 
between activated MMPs and the endogenous 
tissue inhibitor of metalloproteinases (TIMPs) 
determine overall MMP proteolytic activity, and 
thus the turnover of airway extracellular matrix. 
Several MMPs including MMP-9 play an important 
role in the pathogenesis of many airway diseases 
such as asthma and chronic obstructive pulmonary 
disease.6,7 An up-regulation of MMP-8 and -9 has 
been reported in human bronchiectatic airways in 
vivo.8 Furthermore, MMP-2 and -9 expression is 
increased in mouse mycoplasma-infected airways in 
vivo.9 
 Studies have shown that mitogen-activated 
protein kinases (MAPKs) are involved in the 
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES
inflammatory response, such as the release of 
IL-8, which progressively destroys pulmonary 
tissue via MMP-9 activation and is associated 
with high mortality.
5. Inhibition of ERK or JNK may be an effective 
therapeutic strategy against the early stages of 
pulmonary P aeruginosa infection, via attenuation 
of the inflammatory cascade.
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regulation of MMPs by various cell types.10,11 The 
MAPK family includes three major members: the 
extracellular signal-regulated kinases (ERKs), the 
c-Jun N-terminal kinase (JNK)/stress-activated 
protein kinases, and p38.12 Although the role of 
MAPKs in the regulation of MMPs has been studied 
in many cell types, little is known about how MAPKs 
regulate the production of MMPs after bacterial 
infection in airway epithelial cells. We hypothesised 
that P aeruginosa infection induces MMP-9 in human 
bronchial epithelial cells via NF-κB activation. As 
NF-κB is a candidate for therapeutic intervention in 
airway inflammation, we also investigated the role of 
NF-κB in the induction of MMP-9 expression after P 
aeruginosa infection. 
 We investigated the expression and activity 
of MMP-9 in human bronchial epithelial cells 
using RT-PCR and gelatin zymography. The role 
of specific MAPK pathways in the activation of 
NF-κB-dependent transcription was addressed 
using NF-κB-dependent transcriptional reporters 
(ie BEAS-2B 6κBtk reporter cell line) and specific 
MAPK inhibitors.
Methods
Cell culture and Pseudomonas aeruginosa 
infection
BEAS-2B cells were grown in Keratinocyte-SFM 
containing 5 ng/ml epidermal growth factor and 50 
μg/ml bovine pituitary extract, and then incubated at 
37ºC in a humidified incubator with 95% air and 5% 
CO2. Passages 41-49 were used. At 90% confluence, 
the culture was changed to growth factor-free 
medium for 24 h prior to treatment.
 Different P aeruginosa strains (one clinical 
isolate from a local patient, PAO1 as a laboratory 
strain [ATCC15692] and ATCC27853 as a reference 
strain) were used at 107 to 105 colony-forming units 
for various time periods. 
Semi-quantitative RT-PCR
Total cDNA was prepared by first-strand cDNA 
synthesis from 1 μg of total RNA isolated from 
cells according to standard protocols. For PCR 
quantification, appropriate primers for IL-8, MMPs 
(MMP-2, MMP-8, and MMP-9) and TIMPs (TIMP-1 
and TIMP-2) were designed according to the 
published sequences. Following amplification, PCR 
products were run on an ethidium bromide-stained 
agarose gel. Bands were quantified by densitometric 
analysis using glyceraldehydes-3-phosphate-
dehydrogenase (GAPDH) as a housekeeping gene. 
Data were expressed as the ratio of gene of interest/
GAPDH.
ELISA
IL-8 was measured in the supernatant using 
commercially available ELISA kits (BD OptEIASet).
Gelatine zymography
Levels of gelatinolytic MMPs, secreted into the 
media, were separated by electrophoresis through 
a 10% polyacrylamide gel containing 0.1% gelatine. 
Positions of gelatinolytic activity were unstained on 
a darkly stained background. The clear bands on the 
zymograms were scanned and the signals quantified 
by densitometric scanning to determine the intensity 
of MMP-9 activity as arbitrary units.
Western blot analysis
After infection with P aeruginosa, protein was 
extracted from cells. Samples (20 μg) were run on 
10% on SDS-polyacrylamide gels with prestained 
molecular weight markers (Bio-Rad) and transferred to 
Hybond-ECL membranes using standard techniques. 
Membranes were blocked with 5% nonfat milk and 
probed with primary antibodies to phosphorylated 
or total ERK1/2, JNK1/2 and p38 (Cell Signaling 
Technology) at a dilution of 1:1000 and incubated 
overnight at 4ºC. HRP-conjugated goat anti-rabbit 
or anti-mouse antibody was used as a secondary 
antibody. In all cases, proteins were visualised using 
enhanced chemiluminescence reagent (Amersham) 
according to the manufacturer’s instructions. 
Luciferase activity assay
The BEAS-2B 6κBtk reporter cell line was generated 
as described previously.13 Luciferase activity was 
determined using a commercially available luciferase 
reporter gene assay system (Promega) under 
luminescence (FLUOstar Plate Reader).
Statistical Analysis
Values were expressed as means±SEM. Data analysis 
was performed using Prism software (GraphPad 
Software). All experiments were carried out with 
materials collected from at least four to six separate 
cell cultures in duplicate or triplicate. Comparison of 
more than two groups was carried out with one-way 
analysis of variance, followed by Bonferroni’s 
multiple comparison post hoc tests. A P value of 
<0.05 was considered statistically significant. 
Results
P aeruginosa–induced IL-8 was released in a dose- 
and time-dependent manner. As the three different 
strains of P aeruginosa released comparable amount 
of IL-8, PAO1 was chosen for further study. Induction 
of IL-8 mRNA expression appeared as early as 1 h 
after exposure to P aeruginosa (preceding the release 
of IL-8) and continued to increase for up to 4 h. 
 Cells were found to express MMP-2 and 
MMP-9, which were secreted in their proforms 
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(proMMP; MMP-2 proform, 72 kD; MMP-9 proform, 
92 kD). P aeruginosa caused a dose-dependent 
increase in MMP-9 production, but the MMP-2 was 
not affected after 6h. Induction of MMP-9 mRNA 
expression was detectable at 1 h and reached plateau 
at 2 h after infection, indicating transcriptional 
regulation. 
 Although phosphorylation of the MAPKs 
ERK, JNK, and p38 at Thr202/Tyr204, Thr183/Tyr185, 
and Thr180/Tyr182 was detectable at 1 h and 
continued to increase up to 2 h after P aeruginosa 
exposure. The MEK and JNK activity inhibitors, 
PD98059 and SP600125 respectively, blunted IL-8 
release and MMP-9 activity in BEAS-2B cells treated 
with P aeruginosa but not p38 MAPK inhibitor 
SB203580. The P aeruginosa–induced IL-8 mRNA 
also diminished in the presence of PD98059 and 
SP600125 but not SB203580, suggesting that P 
aeruginosa–induced ERK and JNK activity partially 
contributed to P aeruginosa–induced IL-8 release 
and MMP-9 activity in BEAS-2B cells.
 Treatment with pyrrolidine dithiocarbamate 
(a NF-κB inhibitor) before P aeruginosa infection 
attenuated P aeruginosa–induced IL-8 release and 
MMP-9 activity. P aeruginosa (either PAO1 or a 
clinical isolate) alone caused a dose-dependent 
increase in NF-κB-dependent transcription, which 
was diminished at ≥10 μM for PD98059 and 
SP600125. 
Discussion
The enzymes of MMP family are important in 
tissue development and regeneration. Inappropriate 
MMP regulation and activation during chronic 
inflammation may lead to disturbances in the 
turnover and remodelling of pulmonary extracellular 
matrix, which could contribute to the structural 
remodelling that occurs after bacterial infection. In 
the present study, P aeruginosa infection induced 
the expressions of IL-8 and MMP-9, the pivotal 
inflammatory mediators through a mechanism 
that involved ERK1, JNK, and NF-κB activation in 
BEAS-2B cells. 
 Lung epithelial cells can be activated directly 
by some microbes, such as P aeruginosa.14 A variety 
of cellular signalling pathways can be altered by acute 
lower respiratory tract infection including MAPK 
signalling and NF-κB activation, among others.15 The 
MPPKs are important transducers of extracellular 
stimuli to the nucleus. The mechanisms of MAPK-
mediated gene expression include the modulation 
of transcription factor activity.16 NF-κB is also an 
important transcription factor activating the IL-8 
promoter.17 In support of NF-κB involvement, 
P aeruginosa infection induced the activity of a 
reporter construct governed by a 6x tandem repeat 
of the NF-κB response element in BEAS-2B cells, 
suggesting that NF-κB might be involved in P 
aeruginosa–induced IL-8 and MMP-9 promoter 
activity. 
 To our knowledge, there is no study addressing 
the significance of ERK and JNK signalling after P 
aeruginosa infection. In accordance with our findings, 
ERK has been linked to production of MMP-9, and 
to IL-8 release in response to lipopolysaccharide 
or Helicobacter pylori through in vitro studies of 
primary monocytes and macrophage cell lines.18,19 
The present study indicated that inhibition of ERK 
or JNK suppressed P aeruginosa–induced increases 
in the luciferase activity of an NF-κB-dependent 
reporter, supporting the possibility of the role of 
ERK or JNK as an upstream activator of NF-κB. An 
ERK- or JNK-NF-κB-linked cascade was important 
in the case of human airway epithelial cells (Fig). 
We therefore suggest that inhibition of ERK or JNK 
may be an effective therapeutic strategy against the 
early stages of pulmonary P aeruginosa infection, via 
attenuation of the inflammatory cascade. 
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FIG.  Schematic diagram of IL-8 and MMP-9 induction by Pseudomonas aeruginosa 
P aeruginosa triggers activation of ERK or JNK which then activates NF-κB as a result of 
the phosphorylation and subsequent degradation of IκB-α which binds to NF-κB and 
anchors it in the cytoplasm. The freed NF-κB translocates to the nucleus and induces 
IL-8 or MMP-9 transcription
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